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Ultraviolet (UV) A-1 (340–400 nm) radiation is highly effective in inducing apoptosis in skin-inﬁltrating T cells and
thereby exerts beneﬁcial effects in patients with T cell-mediated skin diseases. In this in vitro study, we report that
malignant and normal T cells differ in their susceptibility toward UVA-1 radiation-induced apoptosis. Dose–
response studies revealed that malignant CD4þ T cells isolated from a patient with adult T cell leukemia and
Sezary’s syndrome as well as malignant T cell lines exhibited a signiﬁcantly higher susceptibility toward UVA-1
radiation-induced apoptosis 4 h (early apoptosis) and 24 h (late apoptosis) after exposure than normal, CD4þ T
cells. This difference was speciﬁc for UVA-1 irradiation because it was not detected when apoptosis was induced in
these cells through exposure to UVB radiation or stimulation with cell-permeable ceramides. It has been shown that
UVA-1 radiation-induced T cell apoptosis is initiated through the generation of singlet oxygen. This is in agreement
with the present observation that stimulation of unirradiated cells with a singlet oxygen-generating system induced
apoptosis in malignant cells to a greater extent than in normal cells. Moreover, downregulation of FAS surface
expression in malignant T cells was associated with the inhibition of UVA-1 radiation/singlet oxygen-induced apop-
tosis in these cells. It was thus of great interest to learn that addition of the caspase inhibitor Z-VADfmk decreased
and interferon-c stimulation, which is known to upregulate caspase levels including caspase-3, increased the
sensitivity of T cells toward UVA-1 radiation-induced apoptosis. Furthermore, malignant T cells had signiﬁcantly
higher procaspase-3 levels when compared with normal cells. These studies indicate that the susceptibility of
human T cells toward UVA-1 radiation-induced apoptosis is related to the availability of caspases such as caspase-
3 and that strategies directed at upregulating caspase levels will increase the efﬁcacy of UVA-1 phototherapy.
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Ultraviolet A-1 (UVA-1; 340–400 nm) radiation phototherapy
was first used a decade ago for the treatment of patients
with acute, severe exacerbation of atopic dermatitis
(Krutmann et al, 1992). Since then, its indication spectrum
has been gradually extended and now includes other T cell-
mediated skin diseases such as cutaneous T cell lymphoma
as well (Krutmann et al, 2001; Krutmann and Morita, 2003).
This development has been fostered by mechanistic studies
that were conducted in atopic dermatitis patients under-
going UVA-1 phototherapy. UVA-1 irradiation of lesional
atopic skin was found to be associated with depletion of
skin-infiltrating CD4þ Tcells, a concomitant downregulation
of the in situ expression of T helper cell-derived cytokines
and the subsequent clearance of eczema (Grewe et al,
1994, 1998). Further in vivo studies revealed that T cell
depletion was preceded by the induction of apoptosis in
skin-infiltrating T cells and it is therefore now generally
accepted that induction of T cell apoptosis is the basic
mechanism of action of UVA-1 phototherapy (Morita et al,
1997).
The signaling pathways involved in UVA-1 radiation-
induced T cell apoptosis have only partially been character-
ized. In vitro, UVA-1 radiation was shown to induce
apoptosis in CD4þ T cells by a mechanism that was initi-
ated through the generation of singlet oxygen and subse-
quently involved the FAS/FASL system (Morita et al, 1997). It
should be noted that UVA-1 radiation caused apoptosis in
human T cells in a biphasic manner with the induction of
early apoptosis after only 1 to 4 h after exposure through a
pathway that is independent of de novo protein synthesis
(preprogrammed cell death) and the induction of late
apoptosis after 16 to 24 h, which requires protein synthesis
(Godar, 1999a).
In patients with atopic dermatitis, optimal therapeutic
responses seem to require relatively high doses of UVA-1
radiation, that is, single doses up to 130 J per cm2 (Dittmar
et al, 2001; Krutmann et al, 2001). In contrast, equivalent
clinical responses could be observed in patients with
cutaneous T cell lymphoma (mycosis fungoides), regardless
of whether 130 J per cm2 or less than half of this dose, 60 J
Abbreviations: FITC, fluorescein; IFN-g, interferon-g; mAb, mono-
clonal antibody; NDP, 3,30-(1,4-naphthylidene)dipropionate; NDPO2,
endoperoxide of 3,30-(1,4-naphthylidene)dipropionate; PBS, phos-
phate-buffered saline; UV, ultraviolet.
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per cm2 were used (Plettenberg et al, 1999). We therefore
speculated that malignant T cells might be more sensitive to
UVA-1 irradiation compared with normal, nonmalignant T
cells. We were particularly interested in testing this hypoth-
esis because the existence of T cell populations with
different UVA-1 susceptibilities, besides the obvious clinical
implications, would provide a unique experimental system
to further study the molecular pathways involved in UVA-1
radiation-induced apoptosis.
In this in vitro study we confirm our hypothesis and
demonstrate for the first time that the sensitivity of human T
cells toward UVA-1 radiation-induced apoptosis is defined
at the level of caspase-3 availability.
Results
To test the hypothesis that malignant T cells are more
susceptible to UVA-1 radiation-induced apoptosis than
normal cells, CD4þ T cells that were freshly isolated from
a patient with adult T cell leukemia, from a patient with
Sezary’s syndrome, and from healthy human volunteers
were exposed in vitro to UVA-1 radiation. Dose–response
experiments revealed that 24 h after irradiation, significantly
more malignant than normal cells were apoptotic (Fig 1a;
po0.05). A similar difference between normal and malig-
nant T cell lines was also observed when normal cells were
compared with malignant cells from five different CD4þ T
cell lines (Fig 1b; po0.05). This difference could also be
detected when malignant (MOLT4) cells and normal cells
were analyzed 4 h after exposure (Fig 1c; po0.05). Note
that analysis at 4 h only revealed T cell apoptosis, which is
due to early protein synthesis-independent mechanisms,
whereas measurements at 24 h after exposure detected
both early and late T cell apoptosis (Morita et al, 1997;
Godar, 1999a). In all future experiments, measurements
were therefore routinely carried out 24 h after irradiation.
To assess whether the observed differences in UVA-1
radiation-induced apoptosis were due to differences in T
cell activation, normal T cells were stimulated for 16 h with 1
mg of the T cell mitogen concanavalin A (‘‘activated T cells’’)
or left unstimulated (‘‘resting T cells’’). Concanavalin A
stimulation slightly increased the percentage of apoptotic T
cells in unirradiated cells by about 5% (Fig 1d). Upon UVA-1
irradiation, however, no significant differences in the
percentage of apoptotic cells was detected between resting
and concanavalin A-stimulated cells.
To study the specificity of this difference, in the following
experiments, T cell apoptosis was induced in these cells
either through UVB irradiation or stimulation with cell
permeable C2- and C6-ceramides. In marked contrast to
UVA-1 irradiation, neither UVB irradiation nor stimulation
Figure 1
Malignant Tcells have a higher sensitivity than normal Tcells toward UVA-1 radiation-induced apoptosis. (a) Freshly isolated malignant Tcells
from adult T cell leukemia and cutaneous T cell lymphoma (Sezary’s syndrome) show a higher susceptibility toward UVA-1 radiation-induced
apoptosis compared with normal CD4þ T cells. (b) Malignant T cell lines are significantly more susceptible toward UVA-1 (20 J per cm2) radiation-
induced apoptosis compared with normal CD4þ T cells. (c) Time kinetics of UVA-1-induced apoptosis in normal and malignant cells. All cells were
irradiated with 20 J per cm2 of UVA-1 and subjected to FACS analysis at the indicated time points. The rate of apoptosis in the irradiated cells was
calculated by subtracting the rate of sham-irradiated controls from the rate of irradiated cells. (d) Nontreated and concanavalin A-activated (16 h, 1
mg) normal T cells do not differ in their susceptibility toward UVA-1 radiation-induced apoptosis. In each experiment, the percentage of apoptotic
cells within the sham-irradiated control cells was always less than 10% and did not differ between the different cell populations. Data are expressed
as percentage annexin V-positive cells 24 h after irradiation and represent the mean  SEM of three independent experiments. po0.05.
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with C2- or C6-ceramides induced apoptosis in malignant
cells at different rates than those obtained for normal,
nonmalignant cells (Fig 2a,b).
UVA-1 radiation-induced apoptosis in normal, nonmalig-
nant T cells can be mimicked in unirradiated cells through
stimulation with singlet oxygen, which was generated
through thermal decomposition of the water-soluble en-
doperoxide NDPO2 (Morita et al, 1997). In this study we
have observed that treatment of cells with NDPO2-induced
apoptosis in malignant cells to a greater extent than in
normal, nonmalignant cells (Fig 3; po0.05). This difference
was comparable to that observed after UVA-1 irradiation.
In previous studies UVA-1 radiation-induced apoptosis in
normal, nonmalignant T cells was found to be mediated
through the FAS/FASL system (Morita et al, 1997). To assess
the role of FAS signaling in UVA-1 radiation-induced
apoptosis in malignant T cells, malignant cells from three
different Jurkat cell lines were analyzed. Wild-type Jurkat
cells had abundant cell surface FAS expression (Fig 4, left
panel). In contrast, C5 cells that had been generated
through repetitive FAS antibody treatment expressed less
FAS molecules on their surface and upon treatment with
anti-FAS antibody did not undergo apoptosis (Caricchio
et al, 1998). Finally, R1 cells, which were generated through
repetitive stimulation of Jurkat cells with FAS antibody and
FASL transfectant, had almost no FAS surface expression
and as a consequence were completely resistant to FAS
antibody or FASL-induced apoptosis (Caricchio et al, 1998).
Upon exposure to UVA-1 radiation, both C5 and R1 cells
exhibited significantly lower apoptosis rates compared with
wild-type Jurkat cells (Fig 4, right panel; po0.05).
In the following experiments we asked whether differ-
ences in FAS signaling would account for the different
susceptibility of normal versus malignant T cells toward
UVA-1 radiation-induced apoptosis. FACS analysis of FAS
surface expression in freshly isolated cells as well as the cell
lines employed in this study, however, did not reveal any
correlation between the level of FAS surface expression and
the susceptibility toward UVA-1 radiation-induced apopto-
sis (data not shown). This is in contrast to the data obtained
with the three Jurkat cell lines shown above (Fig 4) and
indicated the possibility that signaling elements of the FAS/
FASL pathway downstream from FAS surface expression
could determine the susceptibility of T cells toward UVA-1
radiation. Accordingly, normal and malignant cells signifi-
cantly differed when compared for caspase-3 availability. As
is shown in Fig 5a, malignant cells, which were highly
susceptible to UVA-1 radiation-induced apoptosis, ex-
pressed higher procaspase-3 levels compared with normal
T cells. Even more important, UVA-1 radiation-induced T cell
apoptosis was significantly reduced in malignant T cells
upon treatment of cells with Z-VADfmk, which has been
shown to prevent T cell apoptosis mainly through inhibition
of caspases including caspase-3 (Fig 5b; po0.05). Also, R1
cells, which were previously shown to be resistant toward
UVA-1 radiation-induced apoptosis (Fig 4) and thus different
Figure 2
Malignant Tcells are exquisitely sensitive to UVA-1, but not to UVB
radiation and ceramide stimulation- induced apoptosis. (a) UVB
radiation induces similar rates of apoptosis in malignant and normal T
cells. The percentage of apoptotic cells within the sham-irradiated
control cells was always less than 10% and did not differ between the
different cell populations. Data represent percentage of annexin V-
positive cells 24 h after irradiation and are expressed as mean
values  SEM of three independent experiments. (b) Ceramide treat-
ment induces similar rates of apoptosis in malignant and normal T cells.
For ceramide treatment, C2 and C6 ceramides were dissolved in
ethanol and added to the culture medium (50 and 100 mM). After 24 h,
cells were washed and subjected to annexin V analysis. Data represent
one of three essentially identical experiments and are depicted as
percentages of annexin V-positive cells.
Figure3
Malignant T cells are more susceptible than normal T cells to
singlet oxygen-induced apoptosis. Singlet oxygen induces higher
apoptosis rates in malignant T cells compared with normal T cells.
po0.05 Singlet oxygen was generated through thermal decomposi-
tion of the endoperoxide of NDPO2. T cells were incubated with NDPO2
(20 mM) or NDP (20 mM). After 24 h, the percentage of apoptotic cells
was determined as described under Materials and Methods. Data are
expressed as percentages of annexin V-positive cells and represent
mean values  SEM of three independent experiments.
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from other malignant T cells such as wild-type Jurkat cells,
also expressed very low procaspase-3 levels (Fig 5a).
Levels of caspases including caspase-3 can be upregulated
in human cells upon stimulation with recombinant human
IFN-g (Dai and Krantz, 1999). In this study, IFN-g stimulation
significantly increased the susceptibility of R1 cells toward
UVA-1 radiation-induced apoptosis and this increase was
significantly reduced by addition of Z-VADfmk (Fig 5c;
po0.05).
Discussion
In this study, malignant T cells showed a higher suscept-
ibility toward UVA-1 radiation-induced apoptosis compared
with normal CD4þ T cells. This difference could not be
attributed to differences in T cell activation, because
activation of normal T cells with the mitogen concanavalin
did not significantly increase the sensitivity of these cells
toward UVA-1 radiation-induced apoptosis. This in vitro
observation provides an explanation for the clinical experi-
ence that in patients with cutaneous T cell lymphoma
(mycosis fungoides), equally good therapeutic responses
were observed regardless of whether single doses of 130 J
per cm2 or less than half of this dose, that is, 60 J per cm2
were employed, although in patients with atopic dermatitis,
which show skin infiltrates consisting of nonmalignant T
cells, the high-dose regimen is required to achieve optimal
results (Dittmar et al, 2001; Krutmann et al, 2001). As a
consequence, the high-dose regimen is no longer used for
the UVA-1 phototherapy of CTCL patients in our depart-
ment as well as in an ongoing international multicenter trial
that compares UVA-1 phototherapy with PUVA for this
indication.
Comparative studies with CD4þ T cells from five healthy
donors revealed some interindividual differences in the
susceptibility of these cells toward UVA-1 radiation-induced
apoptosis (data not shown). These differences, however,
were not significant (chi-square test for goodness of fit),
whereas significant differences could be detected between
normal cells from each of the five donors and the malignant
cells tested in this study (po0.05). UVA-1 radiation-induced
T cell apoptosis is thought to be mediated through the
generation of singlet oxygen (Morita et al, 1997; Godar,
1999a). Future studies will therefore have to test the
hypothesis that interindividual differences in the antioxidant
status of skin-infiltrating T cells are of relevance for the
susceptibility of their donors toward UVA-1 radiation
phototherapy.
The increased susceptibility of malignant T cells was
found to be relatively specific, because a difference
between malignant and normal cells could only be detected
if apoptosis was induced by irradiating cells with UVA-1, but
not if apoptosis was induced through UVB irradiation or
stimulation with apoptogenic doses of cell-permeable
ceramides. This observation further supports the concept
initially developed by Godar (1999b) that UVA-1 and UVB
radiation induce T cell apoptosis through fundamentally
different mechanisms. It also implies that ceramides, which
have been shown to mediate UVA-1 radiation-induced
biologic effects in human epithelial cells (Grether-Beck
et al, 2000), are unlikely to be involved as second
messenger in UVA-1 radiation-induced T cell apoptosis.
From a clinical point of view one could therefore argue that
UVA-1 radiation represents the UV region of choice for the
treatment of patients with cutaneous T cell lymphoma. In
this regard it is important that UVA-1 radiation-induced T
cell apoptosis is mediated through the generation of singlet
oxygen (Morita et al, 1997; Godar, 1999a). This is in line with
the present observation that induction of apoptosis in T cells
through stimulation with a singlet oxygen-generating sys-
tem revealed significant differences between normal and
malignant T cells, which were essentially identical to those
observed after UVA-1 irradiation of cells. Singlet oxygen
generation may therefore represent a therapeutic principle
for the management of malignant T cell diseases.
An increased susceptibility of malignant (proliferating
cells) compared with nonmalignant cells (quiescent cells)
has also been observed if tumor cells and normal cells are
exposed to ionizing radiation (Kaplan, 1981). In this regard
the ‘‘Law of Bergonie´ and Tribondeau’’ states that (1)
proliferating cells are more susceptible than nonproliferating
Figure 4
Involvement of FAS in UVA-1 radiation-induced
apoptosis in Jurkat cells. The FACS histograms in
the left panel depict FAS surface expression in three
different Jurkat cell lines. Wild-type Jurkat cells have
abundant FAS expression on the surface. The C5 cell
line shows less FAS expression and upon treatment
with anti-FAS antibody does not undergo apoptosis
(Caricchio et al, 1998; data not shown). The R1 cell line
shows almost no FAS expression on the surface
expression and as a result is resistant to FAS antibody
and FASL treatment (data not shown). To assess the
susceptibility of these cells toward UVA-1 radiation-
induced apoptosis, cells from each Jurkat line were
exposed to 20 J per cm2 UVA-1, and 24 h later, the
percentage of annexin V-positive cells was determined
by FACS analysis as described under Materials and
Methods (right panel). The percentage of apoptotic cells
within the sham-irradiated control cells was always less
than 10% and did not differ between the different cell
populations. Data represent mean values  SEM of
three independent experiments. po0.05.
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cells and that (2) morphologically and physiologically
undifferentiated cells are more susceptible than differen-
tiated cells. It should be noted, however, that not for all cell
types differences in the susceptibility toward ionizing
radiation can be explained by these two rules (Haber and
Rothstein, 1969).
In this study, UVA-1 radiation-induced T cell apoptosis
was shown to involve caspase, in particular caspase-3,
activation. Accordingly, UVA-1 radiation-induced apoptosis
was significantly inhibited through addition of the caspase
inhibitor Z-VADfmk. In addition, T cells with a low sensitivity
toward UVA-1 radiation-induced apoptosis such as normal,
nonmalignant cells as well as R1 cells expressed lower
levels of procaspase-3 compared with T cells that were
characterized by a higher susceptibility toward UVA-1
radiation-induced apoptosis, that is, MOLT4, adult T cell
leukemia, ALL, and wild-type Jurkat cells. Finally, treatment
of R1 cells with IFN-g significantly increased the sensitivity
of these cells toward UVA-1 radiation-induced apoptosis,
and this increase was significantly inhibited through addi-
tion of Z-VADfmk, indicating that the IFN-g effect was
mainly due to upregulation of caspase levels, as has
previously been reported to be the case for human cells
(Dai and Krantz, 1999). Based on these observations we
would like to propose that caspases such as caspase-3
represent molecular sensors for the susceptibility of T cells
toward UVA-1 radiation/singlet oxygen-induced apoptosis.
It should be noted that the caspase inhibitor employed in
the present study is not specific for caspase-3 and that
IFN-g treatment, in addition to caspase-3, also induces
upregulation and activation of caspases-8 and -9. It is
therefore possible that the availability of other caspases
at least partially controls UVA-1 radiation/singlet oxygen-
induced T cell apoptosis as well.
To the best of our knowledge, this is the first report to
suggest a critical role for caspases in defining the
susceptibility of pathogenetically relevant T cells toward a
phototherapeutic regimen. The present observation that
stimulation of T cells with IFN-g, and possibly also IFN-a
(Thyrell et al, 2002), significantly enhances UVA-1 radiation-
induced Tcell apoptosis indicates that strategies directed at
upregulating caspase levels will increase the efficacy of
UVA-1 phototherapy and might prompt further interest in
combination regimens of these cytokines with UVA-1
phototherapy for atopic dermatitis and cutaneous T cell
lymphoma.
Materials and Methods
Reagents and antibodies Anti-FAS monoclonal antibody (mAb)
UB2, anti-procaspase-3 mAb CPP32 and fluorescein (FITC)-
labeled annexin V were purchased from MBL (Nagoya, Japan).
C-2 and C-6 ceramides were purchased from Cayman Chemical
(Ann Arbor, MI). Recombinant human interferon-g (IFN-g) was
purchased from PeproTech (Rocky Hill, NJ). Concanavalin A was
obtained from Sigma Chemical Co. (St. Louis, MO).
Isolated cells and cell lines CD4þ T cells were prepared from a
patient with adult T cell leukemia or from a patient with a leukemic
form of a cutaneous T cell lymphoma (Sezary’s syndrome) or from
five different healthy human volunteers (normal, nonmalignant T
cells) by isolating peripheral blood mononuclear cells from the
venous blood of these individuals using Ficoll-Paque density
gradient (Amersham Pharmacia Biotech, Uppsala, Sweden) cen-
trifugation as previously described (Krutmann et al, 1990). CD4þ T
cells were positively selected by magnetic cell sorting using
VarioMACS sorting device (Milteny Biotec, Bergisch-Gladbach,
Germany). The purity of CD4þcells was greater than 95%, as was
assessed by FACS analysis using the anti-CD4 mAb MT310
(DakoCytomation A/S, Copenhagen, Denmark) and a FACScan
Figure 5
Relevance of caspase-3 levels for the sensitivity of T cells towards
UVA-1 radiation-induced apoptosis. (a) Western blot analysis of
procaspase-3 levels in normal and malignant T cells. Ten-microgram
lysates of unirradiated cells were equally loaded to each lane. Data
represent one of three essentially identical experiments. (b) UVA-1
radiation-induced apoptosis in Jurkat cells (wild type) is inhibited by the
caspase inhibitor Z-VADfmk. Cells were incubated with 40 mM Z-
VADfmk for 1 h at 371C. The cells were then washed with PBS and
irradiated with UVA-1 (20 J per cm2). After 24 h, the cells were
harvested and the percentage of annexin V-positive cells was assessed
by FACS analysis. The percentage of apoptotic cells within the sham-
irradiated control cells was always less than 10% and did not differ
between the different cell populations. Data are expressed as mean
values  SEM of three independent experiments. po0.05. IFN-g
treatment enhances UVA-1 radiation-induced apoptosis in FAS-
depleted Jurkat cells (R1). po0.05. For IFN-g treatment, cells were
incubated with 8000 units of recombinant human IFN-g 6 h before UVA-
1 irradiation. The enhancement of UVA-1 radiation-induced apoptosis
by IFN-g was significantly inhibited through addition of Z-VADfmk. Data
represent mean values  SEM of the percentage of annexin V-positive
cells, which were analyzed 24 h after irradiation, of three independent
experiments. po0.01.
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flow cytometer (BD Immunocytometry Systems, Mountain View,
CA) as described below. Freshly isolated cells were UV irradiated
immediately after isolation. Malignant T cell lines used in this study
included HUT 102, HPB-ALL, and ATL 102, which were all provided
by S. Iida (Graduate School of Medical Sciences, Nagoya City
University, Nagoya, Japan), as well as Jurkat and MOLT4, which
were obtained from the Riken cell bank (Tsukuba, Japan). FASL-
transfectant, variant FAS-expressing Jurkat cell lines (given by R.
Caricchio, University of Pennsylvania, Philadelphia, PA) were
employed for the study (Caricchio et al, 1998). These cell lines
were either FAS-antibody- or FASL-transfectant-resistant. They
expressed less or almost no FAS on the surface. All cells were
cultured in RPMI 1640 (Sigma Chemical Co.) supplemented with
10% heat inactivated fetal calf serum and washed once in
phosphate-buffered saline (PBS) before exposure to UV radiation.
In vitro UV irradiation Cultured or freshly isolated cells were
harvested and resuspended in PBS in 6-cm tissue culture dishes
(Becton Dickinson Labware, Franklin Lakes, NJ). Lids were
removed and cells (5  105/mL) were exposed to UVA-1 radiation
from a partial-body UVA-1 irradiation device (Sellamed 2000
system, Dr. Sellmaier, Sellas GmbH, Gevelsberg, Germany) as
previously described (Morita and Krutmann, 2000). The emission
was filtered with a UVA-1 filter (Sellas GmbH) and an infrared
absorbing filter UG1 (Schott, Mainz, Germany) and consisted
exclusively of wavelengths in the range of 340 to 450 nm. The UVA-
1 irradiance was measured with a IL 1700 research radiometer
(International Light, Newburyport, MA) and a IL SED 038 detector
(International Light) and found to be 50 mW per cm2 at a tube to
target distance of 30 cm. For UVB irradiation, UVB Torex FL20S
lamps (Toshiba, Tokyo, Japan) were used, which emit their energy
primarily in the range of 290 to 320 nm with a peak emission at 305
nm. The UVB output of these lamps was measured with an UVR-
3036/S2 radiometer and an UVB detector (Clinical Supply,
Gifuhashima, Japan) and found to be 0.4 mW per cm2 at a tube-
to-target distance of 25 cm. Control cells were sham irradiated;
that is, they were treated identically, however, without exposure to
UVA-1 or UVB radiation. In these cells, the rate of apoptosis was
always less than 10% and did not differ from that observed in
malignant or normal cells before irradiation. After exposure to
either UVB or UVA-1 radiation, cells were kept in their culture
medium at 371C at 5% CO2 for the indicated periods before further
analysis.
Singlet oxygen generation Singlet oxygen was generated by
thermal decomposition of the endoperoxide of the disodium salt of
3,30-(1,4-naphthylidene)dipropionate (NDPO2), 1 mM in PBS, for 1
h in the dark at 371C yielding excited singlet molecular oxygen and
3,30-(1,4-naphthylidene)dipropionate (NDP). This singlet oxygen
generating system previously proved to be well suited for use in T
cell cultures (Morita et al, 1997), because it is water-soluble and
nontoxic up to 40 mM for 1 h of incubation. Infrared emission of
singlet oxygen was measured with a liquid-nitrogen-cooled
germanium photodiode detector (Model EO-817 L, North Coast
Scientific Co., Santa Rosa, CA) as described. The rate of singlet
oxygen generation was monitored by the formation of NDP. Fifteen
minutes after addition of 1 mM NDPO2 the rate of singlet oxygen
generation was 3 mM per min. As controls, cells were stimulated
with NDP, which had been generated through thermal decomposi-
tion from the same batch of NDPO2 used in these experiments.
Detection of apoptosis The number of apoptotic T cells was
determined by FACS analysis as the percentage of annexin Vþ
cells. During the process of apoptosis, cells display phosphatidyl
serine at the cell surface membrane. This very early event in T cell
apoptosis can be detected in T cells undergoing early protein
synthesis-independent as well as late protein synthesis-dependent
apoptosis and was therefore a suitable biologic endpoint for
monitoring T cell apoptosis in the present study (Godar, 1999a). In
brief, irradiated cells were harvested at the indicated time points,
washed once with PBS, and incubated with FITC-labeled annexin
V (MBL, Nagoya, Japan) for 15 min at room temperature. Cells
were then washed again and resuspended in PBS at a concentra-
tion of 2  106 cells per mL and immediately subjected to FACS
analysis as described below. For each variable, 104 cells were
analyzed. Data are given as percentage annexin V-positive cells.
Immunoﬂuorescence ﬂow cytometry Cells (5  105) were
washed twice in PBS, resuspended, and incubated with FITC-
conjugated anti-human CD95 mAb UB2 (MBL, Nagoya, Japan) or a
FITC-conjugated isotype control (MBL) for 30 min at 41C. The cells
were washed twice in PBS and subsequently analyzed using a
FACScan flow cytometer (BD Immunocytometry Systems). For
each variable, 104 cells were analyzed. Data are given as
histograms of fluorescence intensity versus cell number.
Western blot analysis Cells were harvested in lysis buffer
containing 0.3% Triton-X (Katayama Chemical, Osaka, Japan),
1 mg per mL leupeptin (Sigma Chemical Co.), and 1 mM
phenylmethylsulfonyl fluoride (Sigma Chemical Co.). Cells were
homogenized by repetitively passing them through a 27-gauge
needle syringe. The protein concentration of each sample was
determined according to bicinchoninic acid protein assay using a
commercially available kit (micro BCA protein assay, Pierce,
Rockford, IL). Equal aliquots of the protein samples (10 mg/sample)
were subjected to 15% gels for SDS-PAGE and then electro-
transferred to polyvinyldivinylidene difluoride membranes (Millipore
Co., Bedford, MA). Nonspecific binding was blocked through
overnight incubation of membranes in 5% skim milk, 0.05% Tween
20 in Tris-buffered saline, pH 7.5. The following day the
membranes were incubated with the anti-caspase-3 mAb CPP32
(MBL) for 2 h at room temperature. Bound primary antibody was
reacted with anti-mouse peroxidase-conjugated IgG (DakoCyto-
mation A/S) for 1 h at room temperature, and chemiluminescence
was detected (ECL, Amersham Pharmacia Biotech, Buckingham-
shire, England). The blot was exposed to hyperfilm (Amersham
Pharmacia Biotech).
Statistical analysis Data analysis was performed by using the
two-tailed Student’s t test to determine the difference between
values obtained in the indicated cells and in controls.
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